Vietnam Medical Genetics Congress and Conference - 1st Edition

The 1st Vietnam Medical Genetics Congress and Conference

On Jul 4, 2019, the 1st Congress of the Vietnam Medical Genetics Association took place at Hanoi Medical University, with the attendance of more than 400 delegates from government departments and agencies, hospitals, and businesses.

Dr. Duong Quoc Chinh - Head of the Department of Genetics and Molecular Biology, National Institute of Hematology and Blood Transfusion, presenting at the conference (Source: Vietnam Medical Genetics Association - VNMGA Fanpage)

VIET HUY Technological Scientific Equipment Co., Ltd was honored to take part as one of the sponsors of this Congress.

The VIET HUY Technological Scientific Equipment Co., Ltd booth at the Congress

In the presentation, Dr. Nguyen Khac Han Hoan outlined the current status of the disease worldwide and in Vietnam, as well as the mechanisms and classification of the disease and the methods for screening and prenatal diagnosis of thalassemia using hematological testing and genetic testing. Thalassemia is one of the most common genetic diseases in Vietnam, with a carrier rate of 2.5% to 6%.

Through the Conference, Viet Huy introduced to researchers and scientists its products and equipment for genetic diagnosis, such as Thalassemia diagnosis and screening, BRCA genes associated with breast cancer, and FH genes associated with high cholesterol using the NGS method, as well as AZF genes in male infertility and Thrombophilia genes associated with cardiovascular disease and miscarriage using the QF-PCR method.

Assoc. Prof. Dr. Tran Duc Phan - Senior Lecturer at Hanoi Medical University, presenting on advances in genetics in medical applications (Source: Vietnam Medical Genetics Association - VNMGA Fanpage)

Assoc. Prof. Dr. Tran Duc Phan - Senior Lecturer at Hanoi Medical University, presenting on advances in genetics in medical applications.

Prof. Dr. Truong Dinh Kiet - Director of the Medical Genetics Institute, Ho Chi Minh City, President of the Stem Cell Association, presenting at the Conference.

Dr. Vu Chi Dung - Director of the Center for Newborn Screening and Rare Disease Management, Vietnam National Children's Hospital; Head of the Department of Endocrinology - Metabolism - Genetics, Vietnam National Children's Hospital, presenting applications of next-generation gene sequencing in undiagnosed diseases in children.

Some other photos from the conference

Viet Huy also provides mutation testing solutions, including test kits for gene mutations in lung cancer, colorectal cancer, and thyroid cancer, and for therapeutically relevant gene mutations such as EGFR, KRAS, BRAF, etc., to identify appropriate and effective targeted therapy for cancer patients. In addition, the Company provides a kit for quantifying the BCR-ABL translocation gene to monitor treatment response in CML with the tyrosine kinase inhibitor imatinib.

Viet Huy product flyer

A Viet Huy representative introducing products to customers